Finance

Lists
AJANTPHARM:NSE
Ajanta Pharma Ltd
3 359,80 ₹
+1,84%
(+60,80) 1D
15 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AJANTPHARM...
Open
3 330,00 ₹
High
3 387,70 ₹
Low
3 313,70 ₹
Mkt. cap
419,43 մլրդ
Avg. vol.
92,18 հզր
Volume
103,48 հզր
Dividend
1,58%
Quarterly dividend
13,25 ₹
Ex-dividend date
05 օգս, 2026 թ.
P/E ratio
36,99
52-wk high
3 796,00 ₹
52-wk low
2 382,00 ₹
EPS
90,83 ₹
Shares outstanding
88,45 մլն
No. of employees
10 հզր
Open
3 330,00 ₹
High
3 387,70 ₹
Low
3 313,70 ₹
Mkt. cap
419,43 մլրդ
Avg. vol.
92,18 հզր
Volume
103,48 հզր
Dividend
1,58%
Quarterly dividend
13,25 ₹
Ex-dividend date
05 օգս, 2026 թ.
P/E ratio
36,99
52-wk high
3 796,00 ₹
52-wk low
2 382,00 ₹
EPS
90,83 ₹
Shares outstanding
88,45 մլն
No. of employees
10 հզր
News stories
From web sources and news partners
Profile
Ajanta Pharma Limited is an Indian multinational pharmaceutical company. The company operates in India, the United States, and over 30 countries across Africa, Southeast Asia, West Asia, and the CIS. It was established in 1973.. Wikipedia
About Ajanta Pharma Ltd
CEO-
Employees10,4 հզր
Founded1973
Headquarters-
Sector-
Last report
30 հլս, 2026 թ.
Fiscal period
Q1 2027
26,72 ₹ / 22,90 ₹
+16,68%beat
Revenue / Est. (INR)
16,26 մլրդ / 15,30 մլրդ
+6,26%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
13,54 մլրդ
13,75 մլրդ
14,22 մլրդ
16,26 մլրդ
Cost of goods sold
3,17 մլրդ
2,86 մլրդ
3,85 մլրդ
3,28 մլրդ
Cost of revenue
3,17 մլրդ
2,86 մլրդ
3,85 մլրդ
3,28 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,17 մլրդ
3,31 մլրդ
3,50 մլրդ
3,81 մլրդ
Operating expense
7,11 մլրդ
7,50 մլրդ
7,05 մլրդ
8,88 մլրդ
Total operating expenses
10,28 մլրդ
10,36 մլրդ
10,90 մլրդ
12,16 մլրդ
Operating income
3,26 մլրդ
3,39 մլրդ
3,32 մլրդ
4,10 մլրդ
Other non operating income
197,10 մլն
164,20 մլն
-447,90 մլն
204,30 մլն
EBT including unusual items
3,41 մլրդ
3,59 մլրդ
3,47 մլրդ
4,47 մլրդ
EBT excluding unusual items
3,41 մլրդ
3,59 մլրդ
4,42 մլրդ
4,47 մլրդ
Income tax expense
806,20 մլն
848,30 մլն
804,10 մլն
1,13 մլրդ
Effective tax rate
23,66%
23,66%
23,17%
25,20%
Other operating expenses
3,51 մլրդ
3,76 մլրդ
3,09 մլրդ
4,63 մլրդ
Net income
2,60 մլրդ
2,74 մլրդ
2,67 մլրդ
3,34 մլրդ
Net profit margin
19,22%
19,91%
18,76%
20,56%
Earnings per share
20,82
21,91
21,34
26,72
Interest and investment income
-
-
516,00 մլն
-
Interest expense
-33,90 մլն
-51,00 մլն
-23,60 մլն
-31,80 մլն
Net interest expenses
-33,90 մլն
-51,00 մլն
492,40 մլն
-31,80 մլն
Depreciation and amortization charges
429,70 մլն
435,10 մլն
453,70 մլն
445,00 մլն
EBITDA
3,68 մլրդ
3,70 մլրդ
3,70 մլրդ
4,49 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps